Hepatitis B and C Co-Infection Are Independent Predictors of Progressive Kidney Disease in HIV-Positive, Antiretroviral-Treated Adults-Reference-Cited by-同舟云学术

Hepatitis B and C Co-Infection Are Independent Predictors of Progressive Kidney Disease in HIV-Positive, Antiretroviral-Treated Adults

Published:2012-07-20 Issue:7 Volume:7 Page:e40245
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mocroft Amanda,Neuhaus Jacqueline,Peters Lars,Ryom Lene,Bickel Markus,Grint Daniel,Koirala Janak,Szymczak Aleksandra,Lundgren Jens,Ross Michael J.,Wyatt Christina M.,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. CD4+ count-guided interruption of antiretroviral treatment.;WM El-Sadr;N Engl J Med,2006

2. Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons.;AI Choi;Circulation,2010

3. Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy.;CM Wyatt;Antivir Ther,2011

4. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America.;SK Gupta;Clin Infect Dis,2005

5. The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis.;CM Wyatt;AIDS,2008

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and predictors of long-term progression of chronic kidney disease in people with HIV in Ghana from 2003–2018;BMC Nephrology;2024-07-29

2. Hepatitis B virus infection as a risk factor for chronic kidney disease: a systematic review and meta-analysis;BMC Infectious Diseases;2024-06-22

3. Renal safety of tenofovir alafenamide-based antiretroviral therapy in people with HIV: A mini-review;BioScience Trends;2024-04-30

4. The changing landscape of HIV-associated kidney disease;Nature Reviews Nephrology;2024-01-25

5. Renal outcomes in adults with HBV, HIV and HBV/HIV coinfection after 3 years of antiviral therapy in urban Tanzania;Journal of Antimicrobial Chemotherapy;2023-11-03